BILIARY TRACT CARCINOMA
Clinical trials for BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo extends life in bile duct cancer trial
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine/cisplatin) helps people with advanced bile duct or gallbladder cancer live longer. Over 1,000 participants received either the combination or chemo plus a placebo. The goal…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 03:07 UTC
-
Promising combo shows hope for tough bile duct cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine/cisplatin) helps people with advanced bile duct cancer live longer. It involved 158 Chinese adults whose cancer had spread or could not be removed by surgery. The main goal…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 13:51 UTC